| Literature DB >> 33834305 |
Gunay Uludag1, Neil Onghanseng1, Anh N T Tran1, Muhammad Hassan1, Muhammad Sohail Halim1,2, Yasir J Sepah1,2, Diana V Do1, Quan Dong Nguyen3.
Abstract
Antiphospholipid syndrome (APS) is an autoimmune disorder associated with obstetrical complications, thrombotic complications involving both arteries and veins, and non-thrombotic manifestations affecting multiple other systems presenting in various clinical forms. Diagnosis requires the presence of antiphospholipid antibodies. The exact pathogenesis of APS is not fully known. However, it has recently been shown that activation of different types of cells by antiphospholipid antibodies plays an important role in thrombosis formation. Ocular involvement is one of the important clinical manifestations of APS and can vary in presentations. Therefore, as an ophthalmologist, it is crucial to be familiar with the ocular findings of APS to prevent further complications that can develop. Furthermore, the ongoing identification of new and specific factors contributing to the pathogenesis of APS may provide new therapeutic options in the management of the disease in the future.Entities:
Keywords: Antiphospholipid antibodies; Antiphospholipid syndrome; Ocular manifestations
Year: 2021 PMID: 33834305 DOI: 10.1186/s12348-021-00240-8
Source DB: PubMed Journal: J Ophthalmic Inflamm Infect ISSN: 1869-5760